NCT06203236View on ClinicalTrials.gov

Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

November 30, 2025

Conditions
Acute Heart FailureChronic Kidney Diseases
Interventions
DRUG

Furosemide 20 MG

"1. The median daily total dose of intravenous loop diuretic at the start of treatment will be 20 mg of furosemide.~2. Monitoring of urinary sodium excretion (natriuresis) and diuresis will begin 2 hours after treatment initiation."

OTHER

diuretic therapy

diuretic therapy

All Listed Sponsors
lead

Assiut University

OTHER